| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.23 | 0.2 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.075 | 0.2 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |